OpGen Inc - רווח למניה אחת ב-12 החודשים האחרונים OPGN

The YoY net income per share growth over the last 12 months on the GURU.Markets chart reflects a trend where the indicator remains around 64.90. OpGen, Inc. (OPGN) maintains premium pricing driven by the exclusivity of its antibiotic resistance tests. The company's environmental focus is based on energy efficiency and the reduction of chemical waste. Furthermore, the business relies on the humanitarian status of its diagnostics, which eliminates the impact of geopolitical sanctions.

OpGen, Inc. (OPGN) automates pathogen diagnostics using CNC cartridges, minimizing manual labor in laboratories. The efficiency of these technologies directly determines the dynamics of net earnings per share. The EPS YoY growth rate (trailing 12 months) measures the annual change of this metric, accounting for currency fluctuations. An upward curve signals an expansion of the dollar margin. Analysis of this chart allows for an assessment of the issuer's fundamental attractiveness.